796 related articles for article (PubMed ID: 34496967)
1. Antimicrobial peptides: mechanism of action, activity and clinical potential.
Zhang QY; Yan ZB; Meng YM; Hong XY; Shao G; Ma JJ; Cheng XR; Liu J; Kang J; Fu CY
Mil Med Res; 2021 Sep; 8(1):48. PubMed ID: 34496967
[TBL] [Abstract][Full Text] [Related]
2. Rediscovery of antimicrobial peptides as therapeutic agents.
Ryu M; Park J; Yeom JH; Joo M; Lee K
J Microbiol; 2021 Feb; 59(2):113-123. PubMed ID: 33527313
[TBL] [Abstract][Full Text] [Related]
3. A New Era of Antibiotics: The Clinical Potential of Antimicrobial Peptides.
Browne K; Chakraborty S; Chen R; Willcox MD; Black DS; Walsh WR; Kumar N
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32987946
[TBL] [Abstract][Full Text] [Related]
4. Synthetic antimicrobial peptides: Characteristics, design, and potential as alternative molecules to overcome microbial resistance.
Lima PG; Oliveira JTA; Amaral JL; Freitas CDT; Souza PFN
Life Sci; 2021 Aug; 278():119647. PubMed ID: 34043990
[TBL] [Abstract][Full Text] [Related]
5. Antimicrobial peptides (AMPs): a patent review (2015-2020).
Annunziato G; Costantino G
Expert Opin Ther Pat; 2020 Dec; 30(12):931-947. PubMed ID: 33187458
[No Abstract] [Full Text] [Related]
6. Antimicrobial Peptides and their Multiple Effects at Sub-Inhibitory Concentrations.
Casciaro B; Cappiello F; Verrusio W; Cacciafesta M; Mangoni ML
Curr Top Med Chem; 2020; 20(14):1264-1273. PubMed ID: 32338221
[TBL] [Abstract][Full Text] [Related]
7. Role and modulation of the secondary structure of antimicrobial peptides to improve selectivity.
Liang Y; Zhang X; Yuan Y; Bao Y; Xiong M
Biomater Sci; 2020 Dec; 8(24):6858-6866. PubMed ID: 32815940
[TBL] [Abstract][Full Text] [Related]
8. Antimicrobial peptides as a promising treatment option against Acinetobacter baumannii infections.
Neshani A; Sedighian H; Mirhosseini SA; Ghazvini K; Zare H; Jahangiri A
Microb Pathog; 2020 Sep; 146():104238. PubMed ID: 32387392
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms and consequences of bacterial resistance to antimicrobial peptides.
Andersson DI; Hughes D; Kubicek-Sutherland JZ
Drug Resist Updat; 2016 May; 26():43-57. PubMed ID: 27180309
[TBL] [Abstract][Full Text] [Related]
10. Antimicrobial peptides as therapeutic agents: opportunities and challenges.
Mahlapuu M; Björn C; Ekblom J
Crit Rev Biotechnol; 2020 Nov; 40(7):978-992. PubMed ID: 32781848
[TBL] [Abstract][Full Text] [Related]
11. Anti-bacterial activity of inorganic nanomaterials and their antimicrobial peptide conjugates against resistant and non-resistant pathogens.
Pardhi DM; Şen Karaman D; Timonen J; Wu W; Zhang Q; Satija S; Mehta M; Charbe N; McCarron PA; Tambuwala MM; Bakshi HA; Negi P; Aljabali AA; Dua K; Chellappan DK; Behera A; Pathak K; Watharkar RB; Rautio J; Rosenholm JM
Int J Pharm; 2020 Aug; 586():119531. PubMed ID: 32540348
[TBL] [Abstract][Full Text] [Related]
12. Chemically modified and conjugated antimicrobial peptides against superbugs.
Li W; Separovic F; O'Brien-Simpson NM; Wade JD
Chem Soc Rev; 2021 Apr; 50(8):4932-4973. PubMed ID: 33710195
[TBL] [Abstract][Full Text] [Related]
13. Selection of antimicrobial frog peptides and temporin-1DRa analogues for treatment of bacterial infections based on their cytotoxicity and differential activity against pathogens.
Gaiser RA; Ayerra Mangado J; Mechkarska M; Kaman WE; van Baarlen P; Conlon JM; Wells JM
Chem Biol Drug Des; 2020 Oct; 96(4):1103-1113. PubMed ID: 31102497
[TBL] [Abstract][Full Text] [Related]
14. Strategies for recombinant production of antimicrobial peptides with pharmacological potential.
Sampaio de Oliveira KB; Leite ML; Rodrigues GR; Duque HM; da Costa RA; Cunha VA; de Loiola Costa LS; da Cunha NB; Franco OL; Dias SC
Expert Rev Clin Pharmacol; 2020 Apr; 13(4):367-390. PubMed ID: 32357080
[TBL] [Abstract][Full Text] [Related]
15. Antimicrobial peptide polymers: no escape to ESKAPE pathogens-a review.
Mukhopadhyay S; Bharath Prasad AS; Mehta CH; Nayak UY
World J Microbiol Biotechnol; 2020 Aug; 36(9):131. PubMed ID: 32737599
[TBL] [Abstract][Full Text] [Related]
16. Antimicrobial and Amyloidogenic Activity of Peptides. Can Antimicrobial Peptides Be Used against SARS-CoV-2?
Kurpe SR; Grishin SY; Surin AK; Panfilov AV; Slizen MV; Chowdhury SD; Galzitskaya OV
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33333996
[TBL] [Abstract][Full Text] [Related]
17. Antimicrobial Peptides and Cell-Penetrating Peptides for Treating Intracellular Bacterial Infections.
Buccini DF; Cardoso MH; Franco OL
Front Cell Infect Microbiol; 2020; 10():612931. PubMed ID: 33614528
[TBL] [Abstract][Full Text] [Related]
18. Recent Applications of Aggregation Induced Emission Probes for Antimicrobial Peptide Studies.
Luu T; Li W; O'Brien-Simpson NM; Hong Y
Chem Asian J; 2021 May; 16(9):1027-1040. PubMed ID: 33723926
[TBL] [Abstract][Full Text] [Related]
19. Towards Robust Delivery of Antimicrobial Peptides to Combat Bacterial Resistance.
Drayton M; Kizhakkedathu JN; Straus SK
Molecules; 2020 Jul; 25(13):. PubMed ID: 32635310
[TBL] [Abstract][Full Text] [Related]
20. Synergism between Host Defence Peptides and Antibiotics Against Bacterial Infections.
Li J; Fernández-Millán P; Boix E
Curr Top Med Chem; 2020; 20(14):1238-1263. PubMed ID: 32124698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
